The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus

PURPOSE: In patients with type 2 diabetes mellitus (T2DM), both sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide receptor agonists (GLP-1 RAs) have demonstrated significant improvements in cardiovascular and kidney outcomes independent of their glycemic benefits. This pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitt, Bertram, Steg, Gabriel, Leiter, Lawrence A., Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090862/
https://www.ncbi.nlm.nih.gov/pubmed/34750713
http://dx.doi.org/10.1007/s10557-021-07291-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090862/
https://www.ncbi.nlm.nih.gov/pubmed/34750713
http://dx.doi.org/10.1007/s10557-021-07291-y

Ejemplares similares